Anticoagulant drug related gene polymorphism detection method based on multiple PCR (Polymerase Chain Reaction)

The use of multiplex PCR technology enables simultaneous analysis of multiple genes, solving the problems of high cost and long time consumption in existing technologies. It provides efficient and low-cost personalized medication recommendations and improves the efficacy and safety of anticoagulant drugs.

CN122445776APending Publication Date: 2026-07-24BEIJING KANGXU MEDICAL LAB CO LTD
2 Cites 1 Cited by

Patent Information

Application Number
CN202610890872.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-06-18
Publication Date
2026-07-24

AI Technical Summary

Technical Problem

Existing gene detection methods are costly, time-consuming, and difficult to perform simultaneous analysis of multiple genes, which limits the widespread application of personalized anticoagulant medication.

Method used

Using multiplex PCR technology, through target screening, primer design, single-pass validation and system optimization, we can simultaneously detect polymorphisms of multiple anticoagulant drug-related genes. Combined with electrophoretic analysis and report generation, we can provide suggestions for personalized medication.

Benefits of technology

It significantly improves testing efficiency, reduces costs, generates highly specific and accurate personalized medication reports, helps doctors develop optimized treatment plans, improves drug efficacy, and reduces adverse reactions.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention discloses an anticoagulant drug related gene polymorphism detection method based on multiple PCR. The method comprises the steps of 1, target screening, 2, primer design, 3, single verification, 4, system optimization, 5, sample detection, 6, product analysis and 7, report generation. Based on the multiplex PCR technology, the method for simultaneously detecting the polymorphism of the multiple anticoagulant drug related genes is developed, and according to the method, by optimizing primer design and a reaction system, multiple sites are amplified in a single reaction, the detection efficiency is remarkably improved, and the cost is reduced. Compared with a traditional method, the method has the advantages of being high in specificity and accuracy, easy to standardize and the like, individualized medication suggestions can be rapidly generated, so that doctors are helped to formulate an optimized treatment scheme, the medicine curative effect is improved, adverse reactions are reduced, and the method is suitable for clinical large-scale sample detection and has a good popularization prospect.
Need to check novelty before this filing date? Find Prior Art